We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Could Predict Young Adults Who Might Go On To Develop Diseases of Aging

By LabMedica International staff writers
Posted on 13 Mar 2024
Print article
Image: A new study has revealed the molecular fingerprint of biological aging (Photo courtesy of 123RF)
Image: A new study has revealed the molecular fingerprint of biological aging (Photo courtesy of 123RF)

Everyone ages differently and two people can often have the same chronological age, but very different biological ages. The future of medicine lies in knowing in advance about how someone is aging and designing personalized interventions to delay disease and extend a person’s health span. Researchers have now identified blood markers that are indicative of healthy aging or accelerated aging processes. These markers offer insights into a person’s biological age—essentially, the rate at which their cells and organs are aging, independent of their actual date of birth. This breakthrough research illuminates the biological pathways and substances that might be foundational to the aging process, providing clues as to why aging varies among individuals. It also proposes potential targets for treatments aimed at slowing the aging process and enhancing the duration of good health. This could lead to the development of a blood test capable of determining biological age in younger adults or identifying individuals at risk of developing age-related diseases.

In the study, researchers at University of Pittsburgh (Pittsburgh, PA, USA) compared 196 older individuals, categorizing them as either healthy or rapid agers based on their performance in simple walking tests. These tests are significant as walking ability integrates cardiovascular, muscular, and neurological health, making it a strong predictor of hospitalization and mortality risk in older adults. The study was unique because it compared rapid agers, aged between 65 and 75 who struggled with these physical tasks but were chronologically younger, against healthy agers, who were 75 and older but could complete the tasks without resting. This approach allowed the researchers to focus on biological rather than chronological age, setting their study apart from others that typically compare young adults to older populations. Through metabolomic analysis of blood samples from both groups, clear differences in metabolites were found between healthy and rapid agers, suggesting that blood metabolites can reflect biological age.

The researchers then established the Healthy Aging Metabolic (HAM) Index from 25 specific metabolites. This index proved more effective in differentiating between healthy and rapid agers than other aging measures. When applied to a separate group of older adults from a study in Wisconsin, the HAM Index successfully predicted individuals' ability to walk outside for 10 minutes without stopping with about 68% accuracy. Further analysis through an artificial intelligence model helped identify three key metabolites as potential promoters of healthy aging or accelerators of rapid aging. Future investigations will explore how these metabolites and their associated molecular pathways influence the aging process, with the goal of finding interventions to slow aging. The researchers also aim to study how younger individuals' metabolomes change over time in order to create a blood test that can estimate the biological age in young adults or predict the onset of aging diseases.

“While it’s great that we can predict biological aging in older adults, what would be even more exciting is a blood test that, for example, can tell someone who’s 35 that they have a biological age more like a 45-year-old,” said Aditi Gurkar, Ph.D., assistant professor of geriatric medicine at Pitt’s School of Medicine. “That person could then think about changing aspects of their lifestyle early — whether that’s improving their sleep, diet or exercise regime — to hopefully reverse their biological age.”

Related Links:
University of Pittsburgh

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.